RVL Pharmaceuticals plc Loss Contingency, Receivable, Current
RVL Pharmaceuticals plc had Loss Contingency, Receivable, Current of $2.60 million as of 2020-12-15, per its 10-Q filed 2021-05-13.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyReceivableCurrent · last filed 2021-05-13
- 2020-12-15: Loss Contingency, Receivable, Current $2.60M.
| Period end | Loss Contingency, Receivable, Current |
|---|---|
| 2020-12-15 | $2.60M 10-Q · filed 2021-05-13 |